Legal & General Group
GBT

Legal & General Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Legal & General Group’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-56,676
Closed -$3.86M – 3476
2022
Q3 		$3.86M Buy
56,676
+1,445
+3% +$79.7K ﹤0.01% 1498
2022
Q2 		$1.76M Buy
55,231
+3,615
+7% +$106K ﹤0.01% 1951
2022
Q1 		$1.79M Buy
51,616
+1,918
+4% +$57.3K ﹤0.01% 2032
2021
Q4 		$1.46M Sell
49,698
-425
-0.8% -$13.2K ﹤0.01% 2142
2021
Q3 		$1.28M Buy
50,123
+11,680
+30% +$343K ﹤0.01% 2175
2021
Q2 		$1.35M Sell
38,443
-1,854
-5% -$72.4K ﹤0.01% 2124
2021
Q1 		$1.64M Buy
40,297
+3,779
+10% +$174K ﹤0.01% 2057
2020
Q4 		$1.58M Sell
36,518
-11,581
-24% -$571K ﹤0.01% 1983
2020
Q3 		$2.65M Sell
48,099
-224
-0.5% -$14.2K ﹤0.01% 1647
2020
Q2 		$3.05M Buy
48,323
+13,881
+40% +$952K ﹤0.01% 1540
2020
Q1 		$1.76M Sell
34,442
-2,598
-7% -$174K ﹤0.01% 1639
2019
Q4 		$2.94M Buy
37,040
+6,920
+23% +$410K ﹤0.01% 1615
2019
Q3 		$1.46M Buy
30,120
+3,454
+13% +$180K ﹤0.01% 1849
2019
Q2 		$1.4M Buy
26,666
+3,921
+17% +$225K ﹤0.01% 1848
2019
Q1 		$1.2M Buy
22,745
+966
+4% +$47.5K ﹤0.01% 1906
2018
Q4 		$894K Buy
21,779
+3,714
+21% +$139K ﹤0.01% 1940
2018
Q3 		$686K Buy
18,065
+1,973
+12% +$87.4K ﹤0.01% 2053
2018
Q2 		$728K Buy
16,092
+793
+5% +$36.1K ﹤0.01% 2019
2018
Q1 		$739K Buy
15,299
+5,942
+64% +$331K ﹤0.01% 2007
2017
Q4 		$371K Sell
9,357
-418
-4% -$15.6K ﹤0.01% 2160
2017
Q3 		$299K Buy
9,775
+460
+5% +$12.9K ﹤0.01% 2219
2017
Q2 		$256K Buy
9,315
+4,499
+93% +$134K ﹤0.01% 2220
2017
Q1 		$178K Buy
4,816
+440
+10% +$11.1K ﹤0.01% 2299
2016
Q4 		$62K Buy
4,376
+2,252
+106% +$39.6K ﹤0.01% 2818
2016
Q3 		$47K Sell
2,124
-2,389
-53% -$45.5K ﹤0.01% 2552
2016
Q2 		$74K Buy
+4,513
New +$91K ﹤0.01% 2267

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Legal & General Group's GBT Position: Q4 2022 in Review

Legal & General Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 56,676 shares — an estimated $3.86M sold.

Legal & General Group first reported a position in GBT in Q2 2016 and held it in 26 quarters. The position peaked at $3.86M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Legal & General Group reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Legal & General Group sold 56,676 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $3.86M.
  • Legal & General Group first reported a position in Global Blood Therapeutics, Inc. in Q2 2016 and held it in 26 quarters.
  • Legal & General Group's Global Blood Therapeutics, Inc. position peaked at $3.86M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Legal & General Group's 13F filing for Q4 2022, filed 14 Feb 2023.